C100H121ClLiN27O11S — CID 167587913
lithium;(2S)-2-hydroxypropanenitrile;4-methylbenzenesulfonamide;methyl 4-(2-chloro-5-methylpyrimidin-4-yl)benzoate;methyl 4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoate;(2R)-2-methyl-4-[4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]phenyl]-4-oxobutanenitrile;4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoic acid;1-(1-methylpiperidin-4-yl)pyrazol-4-amine;hydroxide (PubChem CID 167587913) has the molecular formula C100H121ClLiN27O11S and a molecular weight of 1951.71 g/mol. Its IUPAC name is lithium;(2S)-2-hydroxypropanenitrile;4-methylbenzenesulfonamide;methyl 4-(2-chloro-5-methylpyrimidin-4-yl)benzoate;methyl 4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoate;(2R)-2-methyl-4-[4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]phenyl]-4-oxobutanenitrile;4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoic acid;1-(1-methylpiperidin-4-yl)pyrazol-4-amine;hydroxide.
| Compound Name | lithium;(2S)-2-hydroxypropanenitrile;4-methylbenzenesulfonamide;methyl 4-(2-chloro-5-methylpyrimidin-4-yl)benzoate;methyl 4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoate;(2R)-2-methyl-4-[4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]phenyl]-4-oxobutanenitrile;4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoic acid;1-(1-methylpiperidin-4-yl)pyrazol-4-amine;hydroxide |
|---|---|
| PubChem CID | 167587913 |
| Molecular Formula | C100H121ClLiN27O11S |
| Molecular Weight | 1951.71 g/mol |
| Exact Mass | 1949.93 |
| IUPAC Name | lithium;(2S)-2-hydroxypropanenitrile;4-methylbenzenesulfonamide;methyl 4-(2-chloro-5-methylpyrimidin-4-yl)benzoate;methyl 4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoate;(2R)-2-methyl-4-[4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]phenyl]-4-oxobutanenitrile;4-[5-methyl-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]benzoic acid;1-(1-methylpiperidin-4-yl)pyrazol-4-amine;hydroxide |
| SMILES | CN1CCC(n2cc(N)cn2)CC1.COC(=O)c1ccc(-c2nc(Cl)ncc2C)cc1.COC(=O)c1ccc(-c2nc(Nc3cnn(C4CCN(C)CC4)c3)ncc2C)cc1.C[C@H](O)C#N.Cc1ccc(S(N)(=O)=O)cc1.Cc1cnc(Nc2cnn(C3CCN(C)CC3)c2)nc1-c1ccc(C(=O)C[C@@H](C)C#N)cc1.Cc1cnc(Nc2cnn(C3CCN(C)CC3)c2)nc1-c1ccc(C(=O)O)cc1.[Li+].[OH-] |
| InChI | InChI=1S/C25H29N7O.C22H26N6O2.C21H24N6O2.C13H11ClN2O2.C9H16N4.C7H9NO2S.C3H5NO.Li.H2O/c1-17(13-26)12-23(33)19-4-6-20(7-5-19)24-18(2)14-27-25(30-24)29-21-15-28-32(16-21)22-8-10-31(3)11-9-22;1-15-12-23-22(26-20(15)16-4-6-17(7-5-16)21(29)30-3)25-18-13-24-28(14-18)19-8-10-27(2)11-9-19;1-14-11-22-21(25-19(14)15-3-5-16(6-4-15)20(28)29)24-17-12-23-27(13-17)18-7-9-26(2)10-8-18;1-8-7-15-13(14)16-11(8)9-3-5-10(6-4-9)12(17)18-2;1-12-4-2-9(3-5-12)13-7-8(10)6-11-13;1-6-2-4-7(5-3-6)11(8,9)10;1-3(5)2-4;;/h4-7,14-17,22H,8-12H2,1-3H3,(H,27,29,30);4-7,12-14,19H,8-11H2,1-3H3,(H,23,25,26);3-6,11-13,18H,7-10H2,1-2H3,(H,28,29)(H,22,24,25);3-7H,1-2H3;6-7,9H,2-5,10H2,1H3;2-5H,1H3,(H2,8,9,10);3,5H,1H3;;1H2/q;;;;;;;+1;/p-1/t17-;;;;;;3-;;/m1.....0../s1 |
| InChIKey | IASGZSBFUIEROJ-UIRWUZOQSA-M |
| XLogP | 12.18 |
| TPSA | 514.41 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 141 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1951.71 |
| LogP ≤ 5 | 12.18 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 36 |
| Structural Alerts | {'alert_name': 'cyanohydrins', 'substructure': 'N/A'} |
|---|